News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 344
- Sources here
- 20
- Companies here
- 12
Active search
344 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Form PRE 14A CADRENAL THERAPEUTICS For: 23 July By Investing.com
The article reports on the filing of Form PRE 14A by CADRENAL THERAPEUTICS for July 23. This filing is a preliminary proxy statement, typically preceding a shareholder meeting or corporate action. The content is brief, primarily acting as an announcement of this regulatory document.
Press Release: Cadre Holdings Declares Quarterly Dividend of $0.10 Per Share
Cadre Holdings, Inc. (CDRE) announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share of common stock. This dividend is payable on August 15, 2024, to stockholders of record as of the close of business on August 1, …
Andretti Acquisition Corp. II - Ordinary Shares - Class A (POLE) News, Articles, Events & Latest Updates
This article provides recent news and updates for Andretti Acquisition Corp. II (NASDAQ: POLE), focusing primarily on fluctuations in its short interest. Multiple reports from MarketBeat detail significant drops and increases in short interest over several months, alongside a brief mention of a stock …
Andrew Peller Limited Announces Mailing of Meeting Materials and Receipt of Interim Order in Respect of Going Private Transaction
Andrew Peller Limited GRIMSBY, Ontario, July 21, 2026 (GLOBE NEWSWIRE) -- Andrew Peller Limited (TSX: ADW.A / ADW.B) ("Andrew Peller" or the "Company") is pleased to announce the mailing of its notice of meeting, management information circular (the "Circular"), forms of proxy and letters …
Sharemaestro market context Price below Trend Line 52 weeks +87.6% · Next-week setup negative 44.8%Press Release: Cadre Holdings Announces Second Quarter 2026 Earnings and Conference Call Information
Cadre Holdings, Inc. announced it will release its second quarter 2026 financial results after market close on Tuesday, August 6, 2026. The company will also host a conference call and live webcast on Wednesday, August 7, 2026, at 9:00 AM ET, to discuss these …
Price to sales forward of Cadre Holdings, Inc. – NYSE:CDRE
This article provides a brief financial overview for Cadre Holdings, Inc. (NYSE: CDRE), focusing on its price-to-sales forward metric. It details where to find financial information, news, and technical data for the company on TradingView. The content primarily serves as a navigation point for …
Cadrenal Therapeutics (NASDAQ: CVKD) seeks approval for 1M-share equity plan and 960K warrant shares
Cadrenal Therapeutics (NASDAQ: CVKD) is seeking stockholder approval for five proposals at its virtual annual meeting on September 24, 2026. Key proposals include electing a Class I director, ratifying their independent auditor, increasing the share reserve for its 2022 Equity Incentive Plan to 1,000,000 …
Cadre Holdings Sets Aug. 6 Call for Second-Quarter Results
Cadre Holdings, Inc. (NYSE: CDRE) will release its second-quarter 2026 financial results on Wednesday, August 5, 2026, after market close. The company has scheduled a conference call for Thursday, August 6, 2026, at 10:00 a.m. ET to discuss these results, featuring remarks from its …
Cadrenal Therapeutics (Nasdaq:CVKD) - Stock Analysis
This report provides a comprehensive stock analysis of Cadrenal Therapeutics (CVKD), highlighting its operations as a late-stage biopharmaceutical company focused on novel therapies for immune and thrombotic conditions. The company is characterized by a small market cap, ongoing financial risks including declining earnings forecasts, …
CDRE,CLAR Revenue Breakdown
This article provides detailed financial and performance data for two companies: Cadre Holdings Inc. (CDRE) and Clarus Corp. (CLAR). It includes key metrics such as market capitalization, income, sales, P/E ratios, dividend information, and various performance indicators over different periods. The data covers insights …
Dream Finders Homes (NYSE: DFH) director discloses 95,512 Class A shares
Dream Finders Homes, Inc. director Steven Fischer has reported direct ownership of 95,512 shares of Class A common stock, par value $0.01 per share, as of July 13, 2026. This disclosure, made via an SEC Form 3 filing, reflects his existing equity position and …
Dream Finders Homes (DFH) director Richard Beckwitt files Form 3 report
Richard Beckwitt, a director at Dream Finders Homes, Inc. (DFH), has filed a Form 3, which is an initial statement of beneficial ownership. This filing indicates no reported buy or sell transactions and no derivative securities positions for Beckwitt. The Form 3 establishes Beckwitt's …
Dream Industrial REIT Announces July 2026 Monthly Distribution
TORONTO, July 22, 2026--(BUSINESS WIRE)--DREAM INDUSTRIAL REIT (TSX: DIR.UN) (the "Trust") announced today its July 2026 monthly distribution in the amount of 5.833 cents per Unit (70 cents annualized). The July distribution will be payable on August 14, 2026 to unitholders of record as …
Cadre Holdings, Inc. (NYSE:CDRE) Declares $0.10 Quarterly Dividend
Cadre Holdings, Inc. (NYSE:CDRE) has declared a quarterly dividend of $0.10 per share, payable on August 14th to shareholders of record on July 31st, with the ex-dividend date also on July 31st. This equates to an annual payout of $0.40 per share and a …
Cadre Holdings stock trades near recent highs as safety gear demand supports revenue growth
Cadre Holdings (NYSE: CDRE) stock is trading near its 52-week highs, driven by strong demand for law enforcement and emergency responder safety equipment. The company reported a 10% revenue increase and stable EBITDA margins in Q1 2026, with adjusted EPS also up year-on-year. Investors …
H.C. Wainwright Maintains Cadrenal Therapeutics(CVKD.US) With Buy Rating, Maintains Target Price $13
H.C. Wainwright has reiterated its Buy rating for Cadrenal Therapeutics (CVKD.US) and maintained its price target at $13. This sustained positive outlook suggests the firm believes in the company's future performance and valuation. The maintained rating and target price indicate stability in the analyst's …
Insiders Give Up US$31k As Children's Place Stock Drops To US$2.64
Insiders at The Children's Place, Inc. experienced a US$31k loss on shares purchased over the past year, as the stock recently dropped by 12% to US$2.64. One director, Muhammad Umair, bought US$50k worth of shares at an average price of US$7.00, indicating a belief …
Cadre Holdings Sets Aug. 14 Payment Date for $0.10 Dividend
Cadre Holdings, Inc. announced a quarterly cash dividend of $0.10 per share, or $0.40 on an annualized basis. The payment is scheduled for August 14, 2026, to shareholders of record as of July 31, 2026. The declaration of future dividends remains at the discretion …
Cadrenal Therapeutics, Inc. SEC Filing (Jul 21, 2026)
This article reports on an SEC filing by Cadrenal Therapeutics, Inc. (CVKD), specifically a Notice of Effectiveness for an S-3 filing dated July 20, 2026. The filing indicates a "Neutral" impact and sentiment. The article also provides recent news and other SEC filings for …
Cadrenal's Phase 2 data show >25% absolute reduction in clotting events
Cadrenal Therapeutics announced the strategic alignment of its clinical portfolio into a Cardiac Acute Critical Care Franchise and has launched a structured process to seek out-licensing, portfolio monetization, or co-development partnerships for its late-stage assets including CAD-1005, frunexian, and tecarfarin. Recent Phase 2 data …
WCM Investment Management LLC Sells 134,361 Shares of Cadre Holdings, Inc. $CDRE
WCM Investment Management LLC significantly reduced its stake in Cadre Holdings, Inc. (NYSE:CDRE) by 36.2% in Q1 2026, selling 134,361 shares, but still owning 237,158 shares valued at $7.0 million. Other institutional investors showed mixed activity, with some increasing their positions, resulting in institutions …
Children’s Place Board Restructures After Director Resignation
The Children’s Place board announced a restructuring following the resignation of director Douglas Edwards, effective July 13, 2026. This has left the Audit Committee temporarily non-compliant with Nasdaq's three-member requirement, which the company aims to rectify before its May 2027 annual meeting. Analysts currently …
Dream Industrial REIT Q2 2026 Financial Results Release Date, Webcast and Conference Call
TORONTO, July 20, 2026--(BUSINESS WIRE)--DREAM INDUSTRIAL REIT (TSX: DIR.UN)("Dream Industrial") will be releasing its financial results for the quarter ended June 30, 2026, on Tuesday, August 4, 2026. Senior management will be hosting a conference call to discuss the financial results. Participants may join …
CDRE Financials: Revenue Breakdown, Margins & Competitor Comparison
This article analyzes Cadre Holdings Inc (CDRE) financials, detailing its revenue breakdown, profitability margins, and competitive standing. The company generates 90.5% of its revenue from products, totaling $140.64M, with a gross margin of 38.71% and a net margin of 1.27%. CDRE is compared against …
Enterprise value to revenue forward of Cadre Holdings, Inc. – NYSE:CDRE
This article displays the enterprise value to revenue forward for Cadre Holdings, Inc. (NYSE: CDRE) on TradingView. It provides market data, financial information, and links to various TradingView products and community features, indicating the company's financial overview.
Responsive Playbooks and the DFH Inflection
This article analyzes Dream Finders Homes Inc. Class A (NYSE: DFH), suggesting a potential shift in near-term sentiment despite broader weak alignment. AI models have generated three trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles. The analysis highlights key support …
ETFs Investing in Cadre Holdings, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold shares of Cadre Holdings, Inc. (CDRE), providing key financial data for each fund. The ETFs cover a range of investment strategies, including passive and active management, across different market capitalizations (small-cap, micro-cap) and sectors, …
Cadrenal Therapeutics (NASDAQ: CVKD) outlines CMO Ferguson's exit deal
Cadrenal Therapeutics (NASDAQ: CVKD) has detailed the terms of its Chief Medical Officer, Dr. James J. Ferguson III's, departure. Dr. Ferguson's resignation is effective July 31, 2026, and the separation agreement includes salary payments through this date, reimbursement of approved business expenses, and company-paid …
Children’s Place (NASDAQ: PLCE) director exit leaves Audit Committee short
The Children's Place announced that director Douglas Edwards resigned from its board, effective July 13, 2026. This departure leaves the company's Audit Committee with only two members, falling short of Nasdaq's three-member requirement. The company has a cure period until May 2027 (its next …